{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:56:04Z","timestamp":1778151364752,"version":"3.51.4"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Transcatheter tricuspid valve intervention (TTVI) has demonstrated safety and efficacy in treating high-risk patients with tricuspid regurgitation (TR). The authors aimed to perform a meta-analysis based on reconstructed time-to-event data to compare the clinical benefit of TTVI with medical therapy (MED).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A systematic literature search was conducted in major databases, including PubMed, Embase, and the Cochrane Library, until 20 October 2023. All studies comparing the outcomes between TTVI and MED were included. The primary outcome was all-cause mortality. The secondary outcomes included heart failure (HF) hospitalization and the composite outcome of all-cause mortality and HF hospitalization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Five studies covering 3826 patients (1146 received TTVI and 2680 received MED) were identified. At 1-year follow-up, TTVI significantly reduced the risk of all-cause mortality compared with MED [hazard ratio (HR) 0.54, 95% CI: 0.39\u20130.74, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.0001]. There was a trend in favor of TTVI in HF hospitalization, although without significant difference (HR 0.70, 95% CI: 0.42\u20131.18, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.18). TTVI was also associated with a decreased risk of composite outcome (HR 0.57, 95% CI: 0.38\u20130.86, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.007). Reconstructed Kaplan\u2013Meier curves illustrated a 1-year overall survival rate of 83.1% in the TTVI group and 68.8% in the MED group. The subgroup analysis of device types yielded consistent results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Compared with MED, TTVI was associated with greater 1-year benefits for patients with symptomatic moderate or greater TR from the aspects of all-cause mortality and HF hospitalization.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000001773","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:02:05Z","timestamp":1724716925000},"page":"6800-6809","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Transcatheter tricuspid valve intervention versus medical therapy for symptomatic tricuspid regurgitation: a meta-analysis of reconstructed time-to-event data"],"prefix":"10.1097","volume":"110","author":[{"given":"Guangguo","family":"Fu","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyu","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghufran","family":"Bagaber","sequence":"additional","affiliation":[{"name":"Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunsheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of Cardiovascular Surgery, Shanghai Geriatric Medical Center, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinmiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of Cardiovascular Surgery, Shanghai Geriatric Medical Center, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China"},{"name":"Department of Cardiovascular Surgery, Shanghai Geriatric Medical Center, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,10]]},"reference":[{"key":"R1-20250824","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcmg.2018.06.014","article-title":"Burden of tricuspid regurgitation in patients diagnosed in the community setting","volume":"12","author":"Topilsky","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ejhf.2398","article-title":"Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities?","volume":"24","author":"Russo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"R3-20250824","first-page":"157","article-title":"Tricuspid regurgitation and long-term clinical outcomes","volume":"21","author":"Chorin","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.pcad.2019.10.009","article-title":"Tricuspid regurgitation is a public health crisis","volume":"62","author":"Enriquez-Sarano","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jacc.2023.08.008","article-title":"Tricuspid valve academic research consortium definitions for tricuspid regurgitation and trial endpoints","volume":"82","author":"Hahn","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/eurheartj\/ehae082","article-title":"Transcatheter treatment of the tricuspid valve: current status and perspectives","volume":"45","author":"Maisano","year":"2024","journal-title":"Eur Heart J"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJMra2216709","article-title":"Tricuspid Regurgitation","volume":"388","author":"Hahn","year":"2023","journal-title":"N Engl J Med"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jss.2017.08.014","article-title":"Risk factors associated with perioperative morbidity and mortality following isolated tricuspid valve replacement","volume":"221","author":"Chen","year":"2018","journal-title":"J Surg Res"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.amjcard.2018.09.016","article-title":"Prevalence and outcomes of isolated tricuspid valve surgery among medicare beneficiaries","volume":"123","author":"Kundi","year":"2019","journal-title":"Am J Cardiol"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/ejcts\/ezz160","article-title":"Isolated reoperation for tricuspid regurgitation after left-sided valve surgery: technique evolution","volume":"57","author":"Chen","year":"2020","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1016\/j.athoracsur.2020.08.091","article-title":"Minimally invasive valve replacement for late tricuspid regurgitation after left-sided valve surgery","volume":"111","author":"Chen","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"R13-20250824","first-page":"e72","article-title":"ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2020","journal-title":"Circulation"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ejcts\/ezx453","article-title":"Mid-term results and risks of isolated tricuspid valve reoperation following left-sided valve surgery","volume":"53","author":"Fang","year":"2018","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.athoracsur.2018.07.013","article-title":"Beating-heart totally endoscopic tricuspid valvuloplasty in reoperative cardiac surgery","volume":"107","author":"Chen","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/eurheartj\/ehaa966","article-title":"The impact of minimally invasive technique on the outcomes of isolated tricuspid valve surgery","volume":"42","author":"Chen","year":"2021","journal-title":"Eur Heart J"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"129","DOI":"10.31083\/j.rcm2405129","article-title":"2022 CMICS expert consensus on the management of isolated tricuspid regurgitation after left-sided valve surgery","volume":"24","author":"Chen","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1093\/eurheartj\/ehad667","article-title":"Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study","volume":"44","author":"Kodali","year":"2023","journal-title":"Eur Heart J"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.jacc.2023.02.049","article-title":"1-year outcomes of transcatheter tricuspid valve repair","volume":"81","author":"Kodali","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcin.2018.10.022","article-title":"Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the International TriValve Registry","volume":"12","author":"Taramasso","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2023.05.008","article-title":"Short-term outcomes of tricuspid edge-to-edge repair in clinical practice","volume":"82","author":"Lurz","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijcard.2020.07.018","article-title":"Natural history of severe tricuspid regurgitation: Outcomes after transcatheter tricuspid valve intervention compared to medical therapy","volume":"320","author":"Cai","year":"2020","journal-title":"Int J Cardiol"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.jacc.2019.09.028","article-title":"Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation","volume":"74","author":"Taramasso","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R24-20250824","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R25-20250824","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R27-20250824","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"R29-20250824","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2288-13-152","article-title":"Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"R31-20250824","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMoa2300525","article-title":"Transcatheter repair for patients with tricuspid regurgitation","volume":"388","author":"Sorajja","year":"2023","journal-title":"N Engl J Med"},{"key":"R32-20250824","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/eurheartj\/ehac735","article-title":"Sex-related characteristics and short-term outcomes of patients undergoing transcatheter tricuspid valve intervention for tricuspid regurgitation","volume":"44","author":"Scotti","year":"2023","journal-title":"Eur Heart J"},{"key":"R33-20250824","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/ejhf.1975","article-title":"Transcatheter tricuspid valve repair in the setting of heart failure with preserved or reduced left ventricular ejection fraction","volume":"22","author":"Kresoja","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R34-20250824","doi-asserted-by":"crossref","first-page":"102055","DOI":"10.1016\/j.cpcardiol.2023.102055","article-title":"Transcatheter edge-to-edge repair for tricuspid regurgitation- a systematic review and meta analysis","volume":"49","author":"Rehan","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"R35-20250824","doi-asserted-by":"crossref","first-page":"101985","DOI":"10.1016\/j.cpcardiol.2023.101985","article-title":"Therapeutic outcomes following isolated transcatheter tricuspid valve repair: a systematic review and meta-analysis","volume":"48","author":"Siddiqui","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"R36-20250824","doi-asserted-by":"crossref","first-page":"131194","DOI":"10.1016\/j.ijcard.2023.131194","article-title":"Clinical outcomes following tricuspid transcatheter edge-to-edge repair with PASCAL: a meta-analysis","volume":"389","author":"Badwan","year":"2023","journal-title":"Int J Cardiol"},{"key":"R37-20250824","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jcin.2020.08.020","article-title":"Functional and echocardiographic improvement after transcatheter repair for tricuspid regurgitation: a systematic review and pooled analysis","volume":"13","author":"Montalto","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"R38-20250824","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.jcin.2021.08.050","article-title":"Clinical outcomes following isolated transcatheter tricuspid valve repair: a meta-analysis and meta-regression study","volume":"14","author":"Bocchino","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"R39-20250824","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jcin.2019.02.042","article-title":"Physiological and clinical consequences of right ventricular volume overload reduction after transcatheter treatment for tricuspid regurgitation","volume":"12","author":"Rommel","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"R40-20250824","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.amjcard.2020.09.022","article-title":"Prognostic implications of increased right ventricular wall tension in secondary tricuspid regurgitation","volume":"136","author":"Fortuni","year":"2020","journal-title":"Am J Cardiol"},{"key":"R41-20250824","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMra2207410","article-title":"Right ventricular failure","volume":"388","author":"Houston","year":"2023","journal-title":"N Engl J Med"},{"key":"R42-20250824","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCHEARTFAILURE.114.001575","article-title":"The hemodynamic basis of exercise intolerance in tricuspid regurgitation","volume":"7","author":"Andersen","year":"2014","journal-title":"Circ Heart Fail"},{"key":"R43-20250824","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4244\/EIJ-D-21-00191","article-title":"Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis","volume":"17","author":"Schlotter","year":"2021","journal-title":"EuroIntervention"},{"key":"R44-20250824","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/CIRCULATIONAHA.119.043275","article-title":"Cost-effectiveness of transcatheter mitral valve repair versus medical therapy in patients with heart failure and secondary mitral regurgitation: results from the COAPT trial","volume":"140","author":"Baron","year":"2019","journal-title":"Circulation"},{"key":"R45-20250824","first-page":"717","article-title":"Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation","volume":"108","author":"Cohen","year":"2022","journal-title":"Heart Br Card Soc"},{"key":"R46-20250824","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jtcvs.2019.05.021","article-title":"Commentary: who needs evidence when patient preference is a Class I indication?","volume":"159","author":"Gaudino","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R47-20250824","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-med-042921-122533","article-title":"Valvular heart disease: new concepts in pathophysiology and therapeutic approaches","volume":"74","author":"Eleid","year":"2023","journal-title":"Annu Rev Med"},{"key":"R48-20250824","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.xjon.2022.06.002","article-title":"Risk stratification for isolated tricuspid valve surgery: still on the way","volume":"11","author":"Chen","year":"2022","journal-title":"JTCVS Open"},{"key":"R49-20250824","doi-asserted-by":"crossref","first-page":"e008108","DOI":"10.1161\/JAHA.117.008108","article-title":"Protein biomarkers of cardiovascular disease and mortality in the community","volume":"7","author":"Ho","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:13:15Z","timestamp":1756062795000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000001773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000001773","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"2024-03-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}